Risk Seen With Merck & Co., Inc.-GlaxoSmithKline Rotavirus Vaccines

Published: Jan 14, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Newer vaccines against rotavirus, a severe diarrheal disease in children, slightly raise the risk of a rare bowel problem that doomed an earlier vaccine, new studies show. But researchers say the modern vaccines are much safer and well worth this very small risk. Rotavirus kills more than 400,000 young children a year, mostly in poor countries.

Help employers find you! Check out all the jobs and post your resume.

Back to news